Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer

British Journal of Surgery

Volumn 102, Issue 8, 2015, Pages 972-978

  Pettersson, D ^a   Lorinc E ^a   Holm, T ^a   Iversen, H ^a   Cedermark, B ^a   Glimelius, B ^a,b   Martling, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CONTROLLED STUDY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATHOLOGY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIAL; RECTAL NEOPLASMS; TIME FACTORS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TIME FACTORS;

EID: 84931394862     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9811     Document Type: Article

References (33)

1. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al,. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al,. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
3. Pahlman L, Glimelius B,. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990; 211: 187-195.
4. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial [see comments]. N Engl J Med 1997; 336: 980-987
5. [published erratum appears in N Engl J Med 1997; 336: 1539 ].
6. Martling A, Holm T, Johansson H, Rutqvist L, Cedermark B,. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma. Cancer 2001; 92: 896-902.
7. Cedermark B, Johansson H, Rutqvist LE, Wilking N,. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995; 75: 2269-2275.
8. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001; 358: 1291-1304.
9. Glimelius B, Grönberg H, Järhult J, Wallgren A, Cavallin-Ståhl E,. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003; 42: 476-492.
10. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, et al,. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004; 72: 15-24.
11. Glimelius B, Holm T, Blomqvist L,. Chemotherapy in addition to preoperative radiotherapy in locally advanced rectal cancer-a systematic overview. Rev Recent Clin Trials 2008; 3: 204-211.
12. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, et al,. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001; 19: 1976-1984.
13. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al,. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811-820.
14. Hatfield P, Hingorani M, Radhakrishna G, Cooper R, Melcher A, Crellin A, et al,. Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 2009; 92: 210-214.
15. Radu C, Berglund A, Pâhlman L, Glimelius B,. Short-course preoperative radiotherapy with delayed surgery in rectal cancer-a retrospective study. Radiother Oncol 2008; 87: 343-349.
16. Pettersson D, Holm T, Iversen H, Blomqvist L, Glimelius B, Martling A,. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 2012; 99: 577-583.
17. Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T,. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer-treatment results at 5-year follow-up. Langenbecks Arch Surg 2012; 397: 801-807.
18. Pettersson D, Cedermark B, Holm T, Radu C, Pâhlman L, Glimelius B, et al,. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010; 97: 580-587.
19. Fokstuen T, Holm T, Glimelius B,. Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer. Radiother Oncol 2009; 93: 293-297.
20. Jörgren F, Johansson R, Damber L, Lindmark G,. Validity of the Swedish Rectal Cancer Registry for patients treated with major abdominal surgery between 1995 and 1997. Acta Oncol 2013; 52: 1707-1714.
21. Sobin LH, Wittekind C,. International Union Against Cancer TNM Classification of Malignant Tumours (6th edn). John Wiley & Sons: New York, 2002.
22. Greene FL, Flemming ID, Fritz A, Balch CM, Haller DG, Morrow M, (eds). AJCC Cancer Staging Manual (6th edn). Springer: New York, 2002.
23. Dworak O, Keilholz L, Hoffmann A,. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23.
24. Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glimelius B,. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol 1997; 43: 133-137.
25. Glimelius B, Beets-Tan R, Blomqvist L, Brown G, Nagtegaal I, Pahlman L, et al,. Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol 2011; 29: 2142-2143.
26. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo L-J, et al,. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844.
27. Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, et al,. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696.
28. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al,. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
29. Bosset J-F, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun R-J, et al,. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 2014; 15: 184-190.
30. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M,. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223.
31. Bujko K, Bujko M,. Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer. Semin Radiat Oncol 2011; 21: 220-227.
32. Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, et al,. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009; 92: 148-163.
33. Glimelius B, Tiret E, Cervantes A, Arnold D,; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi81-vi88.